OTCMKTS:CBBT Cerebain Biotech (CBBT) Stock Price, News & Analysis $0.0009 0.00 (0.00%) (As of 09/2/2021) Add Compare Share Share Stock Analysis Stock Analysis About Cerebain Biotech Stock (OTCMKTS:CBBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cerebain Biotech alerts:Sign Up Key Stats Today's Range$0.0008▼$0.001050-Day Range N/A52-Week Range$0.00▼$0.47Volume2.04 million shsAverage Volume11.21 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA.Read More… Receive CBBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cerebain Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address CBBT Stock News HeadlinesCBBT expansion back in motion after crews discover centuries-old anchor, halting project for monthsAugust 29, 2024 | msn.comImClone Founder Waksal Forming New Biotech VentureOctober 28, 2023 | thestreet.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.December 22, 2024 | Crypto Swap Profits (Ad)Duopharma Biotech Bhd (DUOP)September 19, 2023 | investing.comFormer Google AI expert raises $100mn for biotech start-upSeptember 10, 2023 | ft.comPharmAla Biotech to supply University of California Clinical Trial with LaNeo™ MDMAOctober 6, 2022 | finance.yahoo.comJapan Biotech Startups Directory 2022September 15, 2022 | finance.yahoo.comCerebain Biotech Closes Share Exchange Agreement With PKG, Inc.September 20, 2021 | finance.yahoo.comSee More Headlines CBBT Stock Analysis - Frequently Asked Questions How have CBBT shares performed this year? Cerebain Biotech's stock was trading at $0.0009 on January 1st, 2024. Since then, CBBT shares have increased by 0.0% and is now trading at $0.0009. View the best growth stocks for 2024 here. How do I buy shares of Cerebain Biotech? Shares of CBBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cerebain Biotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cerebain Biotech investors own include Bionano Genomics (BNGO), Aurora Cannabis (ACB), HUMBL (HMBL), Carnival Co. & (CCL), Canopy Growth (CGC), Enzolytics (ENZC) and SNDL (SNDL). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryWholesale Current SymbolOTCMKTS:CBBT CUSIPN/A CIKN/A Webwww.cerebain.com Phone(714) 371-4109FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (OTCMKTS:CBBT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerebain Biotech Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerebain Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
